Short-Term Therapy with Peroxisome Proliferation-Activator Receptor-Agonist Wy-14,643 Protects Murine Fatty Liver Against Ischemia-Reperfusion Injury

Citation

Teoh, N, Williams, J, Hartley, J et al 2010, 'Short-Term Therapy with Peroxisome Proliferation-Activator Receptor-Agonist Wy-14,643 Protects Murine Fatty Liver Against Ischemia-Reperfusion Injury', Hepatology, vol. 51, no. 3, pp. 996-1006.

Year

2010

ANU Authors

Field of Research

  • Gastroenterology And Hepatology

Updated:  05 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers